Towards electrochemical sensing of gemcitabine release from hybrid nanoparticles in pancreatic cancer cells
Abstract
Theranostic clinical translation has been hindered by the lack of analytical tools facilitating interrogation. Here we report the detection of a chemotherapeutic agent, gemcitabine, released via heat trigger, from a hybrid iron oxide–gold theranostic nanoparticle surface in vitro in pancreatic cancer cells by electrochemiluminescence directly addressing this analytical gap.
- This article is part of the themed collection: Advances in Nanomaterials for Sensors in Early Disease Diagnosis

Please wait while we load your content...